Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.880
-0.170 (-3.37%)
Feb 26, 2026, 4:00 PM EST - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $183.61 million as of February 26, 2026. Its market cap has increased by 2.78% in one year.
Market Cap
183.61M
Enterprise Value
50.55M
1-Year Change
2.78%
Ranking
Category
Stock Price
$4.88
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $183.61M, a decrease of -69.17%. That is a compound annual growth rate of -13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 181.00M | 13.04% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 189.86M |
| SAB Biotherapeutics | 187.09M |
| Jyong Biotech | 186.10M |
| Karyopharm Therapeutics | 185.09M |
| Nkarta | 183.97M |
| Caribou Biosciences | 182.26M |
| Tiziana Life Sciences | 178.67M |
| ProMIS Neurosciences | 178.10M |